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Stroke
BASIC AND TRANSLATIONAL SCIENCES

Ischemic Cerebral Endothelial Cell–Derived
Exosomes Promote Axonal Growth
Yi Zhang , PhD*; Yi Qin, PhD*; Michael Chopp, PhD; Chao Li , PhD; Amy Kemper, BS; Xianshuang Liu, MD, PhD;
Xinli Wang, PhD; Li Zhang, MD; Zheng Gang Zhang , MD, PhD
BACKGROUND AND PURPOSE: Cerebral endothelial cells (CECs) and axons of neurons interact to maintain vascular and neuronal
homeostasis and axonal remodeling in normal and ischemic brain, respectively. However, the role of exosomes in the
interaction of CECs and axons in brain under normal conditions and after stroke is unknown.
METHODS: Exosomes were isolated from CECs of nonischemic rats and is chemic rats (nCEC-exos and isCEC-exos),
respectively. A multicompartmental cell culture system was used to separate axons from neuronal cell bodies.
RESULTS: Axonal application of nCEC-exos promotes axonal growth of cortical neurons, whereas isCEC-exos further enhance
axonal growth than nCEC-exos. Ultrastructural analysis revealed that CEC-exos applied into distal axons were internalized
by axons and reached to their parent somata. Bioinformatic analysis revealed that both nCEC-exos and isCEC-exos
contain abundant mature miRNAs; however, isCEC-exos exhibit more robust elevation of select miRNAs than nCEC-exos.
Mechanistically, axonal application of nCEC-exos and isCEC-exos significantly elevated miRNAs and reduced proteins in
distal axons and their parent somata that are involved in inhibiting axonal outgrowth. Blockage of axonal transport suppressed
isCEC-exo–altered miRNAs and proteins in somata but not in distal axons.
CONCLUSIONS: nCEC-exos and isCEC-exos facilitate axonal growth by altering miRNAs and their target protein profiles in
recipient neurons.
GRAPHIC ABSTRACT: An online graphic abstract is available for this article.
Key Words: axons ◼ cell body ◼ endothelial cells ◼ exosomes ◼ microRNAs

S

troke is a leading cause of morbidity. Neurovascular
coupling, including stroke-induced angiogenesis and
axonal remodeling, is one of the key contributors to
brain repair processes after stroke, which leads to spontaneous and most often incomplete functional recovery.1,2
Angiogenesis is an orchestrated process that requires a
switch of relatively quiescent cerebral endothelial cells
(CECs) to activated phenotype in the peri-infarct area
where the survival neurons often undergo spontaneous
axonal outgrowth.3,4 Communications between strokeactivated CECs and axonal sprouting have not been fully

investigated, although sprouting cerebral blood vessels
and neurites share the same group of genes that guide
axonal remodeling.5,6 Elucidating cellular and molecular
mechanisms that underlie this communication may provide new therapeutic targets for facilitating neurovascular remodeling, consequently resulting in improvement of
neurological function during stroke recovery.
Exosomes (diameter of ≈30–100 nm), small extracellular vesicles (<100 nm), are nanovesicles originating from the fusion of endosomes and multivesicular
bodies with the cell plasma membranes.7,8 Exosomes
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Nonstandard Abbreviations and Acronyms
CEC
cerebral endothelial cell
CSPG
chondroitin sulfate proteoglycan
nCEC-exo	exosome derived from nonischemic
cerebral endothelial cells
isCEC-exo	exosome derived from ischemic cerebral endothelial cells
PCR
polymerase chain reaction
premiRNA precursor miRNA

are essential components of cell-cell communication
by transferring their cargo of proteins, lipids, and RNAs
between source and recipient cells.9,10 Emerging data
indicate that exosomes derived from glial cells and
mesenchymal stromal cells regulate neuronal function by transferring cargo of proteins and miRNAs.11–14
Fruhbeis et al12 demonstrated that exosomes from
oligodendrocytes can be internalized by distal axons
of embryonic cortical neurons and thereby improve
neuronal viability under conditions of cell stress. We
have shown that exosomes derived from mesenchymal stromal cells transfer miRNAs including the miR17-92 cluster to distal axons of cortical neurons and
promote axonal growth even in the presence of axonal
inhibitory chondroitin sulfate proteoglycans (CSPGs).14
These data suggest that distal axons can internalize exosomes and that transfer of exosome miRNAs
may modulate axonal function. However, it is unknown
whether exosomes derived from CECs activated by
stroke play a role in axonal growth.
In the present study, we used cortical neurons cultured in a multicompartmental culture device as a model
system to investigate the effect of exosomes derived
from nonischemic and ischemic CECs (nCEC-exos and
isCEC-exos, respectively) on axonal growth and on
changes of endogenous miRNA profiles within recipient neurons. Our findings indicate that both nCEC-exos
and isCEC-exos significantly promote axonal growth;
however, isCEC-exos exhibit a more robust effect on
axonal growth by modulating axonal and somal miRNAs
and their target proteins that are involved in mediating
axonal growth.

MATERIALS
All experimental procedures were performed in accordance with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals and approved by the
Institutional Animal Care and Use Committee of Henry Ford
Hospital. The data that support the findings of this study
are available from the corresponding author, upon reasonable request. Please see Materials in the Data Supplement
for expanded Methods.
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Cortical Neurons Cultured in Microfluidic
Devices
Cortical neurons were harvested from embryonic day-18 Wistar
rats (Charles River), in which the sex cannot be identified,
according to published protocols.14,15
Two types of axonal microfluidic chamber devices were used:
(1) Standard Device (SND450; Xona Microfluidics; Figure IA in
the Data Supplement)16 and (2) Triple Chamber Neuron Device
(TCND500; Figure IIA and IIB in the Data Supplement).17

Animal Model and Primary Culture of Rat CECs
Young adult male Wistar rats (3 months old, 270–300 g;
Charles River) were subjected to transient (1 hour) middle cerebral artery occlusion according to our published protocols.18,19
Animals were euthanized 7 days after transient (1 hour) middle
cerebral artery occlusion when angiogenesis is at a peak.19
Male rats were used based on data that angiogenesis in the
ischemic brain has been well characterized in male but not in
female ischemic rats.18,20 CECs were isolated from nonischemic
adult male rats (n=4) or rats subjected to 7 days of transient
(1 hour) middle cerebral artery occlusion (n=4), respectively,
according to published protocols, and >90 % of isolated CECs
exhibited phenotypes of endothelial cells.20,21 The CECs were
cultured in CEC growth medium for 4 to 7 days when CECs
reached ≈60% confluence. Then, fetal bovine serum was
replaced with exosome-depleted fetal bovine serum (System
Biosciences) for additional 48 to 72 hours. After that, the conditioned medium was collected for isolation of exosomes.

Isolation and Characterization of Exosomes
From CECs
Exosomes were isolated from the conditioned medium according to our published protocol.22 The particle numbers and size
of CEC-exos were analyzed by nanoparticle tracking analysis
of Nanosight (NS300; Malvern Panalytical).
Ultrastructural morphology and proteins in collected exosomes were examined by means of transmission electron microscope (EM208; Phillips) and Western blotting, respectively.

Experimental Protocol of Axonal Growth
To examine the effect of exosomes on axonal growth, exosomes
were placed into the axonal compartment of the SND450 and
TCND500 devices on 3 days in vitro and 5 days in vitro, respectively, and the total length of axons and growth cone extension
were measured according to our published protocols.15,22,23
To analyze growth cone extension, a time-lapse microscope
was used.
To assess the effects of CSPGs and the soluble form
of Sema6A (Semaphorin 6A) (Sema6A-Fc) on axonal
growth in the presence of exosomes, CSPGs at 2 μg/mL23
(MilliporeSigma) or Sema6A-Fc at 10 nM24 (R&D Systems)
along with exosomes was applied to the axonal compartment of SND450 on 3 days in vitro for 24 hours.
To examine the effect of exosomes on axonal transport, the
movement of endosomes/lysosomes labeled by lysotracker
(ThermoFisher Scientific) within the axons was analyzed.25
To block the axonal transport, emetine (2 μM) was added
into the proximal axon compartment (proximal axon; Figure II in
Stroke. 2020;51:3701–3712. DOI: 10.1161/STROKEAHA.120.031728
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Exosome Labeling and Immunogold Staining
Two sets of exosome labeling were used. To label fresh
harvested exosomes, an Exo-Fect exosome transfection
kit (System Biosciences, CA) was used as reported previously.22 To specifically label exosomes, CEC-exos with the
presence of GFP proteins (CEC–GFP-exos) were generated according to our published protocol. 26 To track axonal internalization of CEC-GFP-exos at the ultrastructural
level, we performed immunogold staining according to our
published protocol. 26

Knockdown of Dicer
To examine the effect of CEC-exo cargo miRNAs on axonal
growth, we transfected CECs with shRNA against Dicer. Levels
of Dicer and miRNAs in dp-Dicer-exo cargo were examined by
means of Western blot and quantitative reverse transcription
PCR, respectively.

Fluorescent In Situ Hybridization and
Immunocytochemistry
Locked nucleic acid probes specifically against rat miR-27a,
miR-19a, and U6 snRNA and scramble probes (Exiqon) were
used for hybridization to detect mature miRNAs according to
a published protocol.27 Immunofluorescent staining was performed and analyzed as described previously.15

Western Blot Analysis
Total proteins in the cell body or in axonal compartments were
extracted. Western blots were performed according to our published protocol.15,22

miRNA Polymerase Chain Reaction Array and
Real-Time Reverse Transcriptase Polymerase
Chain Reaction
Total RNA in axons and cell bodies of cortical neurons or in
CEC-exos was isolated using the miRNeasy Mini kit (Qiagen)
as reported.15,22,23
MiRNA profiles were analyzed using a miRNA polymerase
chain reaction (PCR) array kit (MIRN-107ZE-1; Qiagen).22,23
TaqMan miRNA assays were performed to verify miRNAs
detected by the miRNA PCR array.
miScript Precursor Assay (Qiagen, Valencia, CA) was used
to determine the precursor miRNA (premiRNA) levels. Analysis
of gene expression was performed using the 2(−ΔΔCt) method.28

Statistical Analysis
All statistical analyses were performed using the GraphPad
Prism 8 (version 8.2.1). One-way ANOVA with Tukey multiple comparisons test was used when comparing >2 groups.
Stroke. 2020;51:3701–3712. DOI: 10.1161/STROKEAHA.120.031728

Student t test was used when comparing 2 groups. Values presented are expressed as mean±SEM. A P<0.05 was considered to be significant.

RESULTS
CEC-Exos Applied to Distal Axons Promote
Axonal Growth of Cortical Neurons
We first characterized extracellular vesicles isolated from
primary nonischemic and ischemic CECs (nCEC-exos
and isCEC-exos, respectively). Our data (Figure III in
the Data Supplement) indicate that extracellular vesicles
isolated from CEC supernatant are enriched with exosomes according to the Minimal Information for Studies
of Extracellular Vesicles 2018 guideline29 and that ischemic CECs do not alter the morphological and characteristic properties of their released exosomes.
We then assessed the effects of nCEC-exos and
isCEC-exos on axonal growth of cortical neurons cultured in microfluidic device SND450 (Figure IA in the
Data Supplement). The axonal application of nCECexos significantly increased axonal growth in a dosedependent manner with a maximum effect at a dose
of 3×107 particles/mL (Figure IB in the Data Supplement). In addition, nCEC-exos significantly enhanced
the speed of growth cone extension with leveling off at
4 hours after treatment (Figure IC in the Data Supplement). Compared with nCEC-exos, isCEC-exos further
significantly enhanced axonal growth and growth cone
extension (Figure 1).

CEC-Exos Applied to Axons Alter Endogenous
miRNAs and Their Target Genes in Recipient
Neurons
Exosomes transfer their cargo miRNAs into recipient
cells and mediate cell function.30,31 The PCR miRNA array
analysis of CEC-exo cargo showed that 24 enriched
miRNAs were found to be >2× higher in isCEC-exos
than in nCEC-exos (Figure 2A; Tables I through III in the
Data Supplement; Figure IV in the Data Supplement).
Taqman miRNA assay verified the levels of 6 miRNAs
(miR-19a, miR-27a, miR-298, miR-125b, miR-34a, and
miR-195) were significantly higher in isCEC-exos than
nCEC-exos (Figure 2A). We then examined the effect
of CEC-exos on axonal miRNAs with PCR miRNA array
and found that compared with nontreated axons, the
6 exosome-enriched miRNAs were among upregulated
miRNAs in axons by CEC-exo treatment (Figure 2B;
Tables IV through VI in the Data Supplement; Figure IV
in the Data Supplement). Quantitative RT-PCR analysis showed that compared with nCEC-exos, isCEC-exo
treatment significantly increased 4 miRNAs (miR-19a,
27a, 298, and 195) in axons, whereas miR-34a and
miR-125b did not significantly increase (Figure 2B).
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the Data Supplement) for 4 hours on 5 days in vitro and then
removed. After that, exosomes were added into the distal axon
compartment (distal axon; Figure II in the Data Supplement).
The growth cone extension was measured by means of the
time-lapse microscope. The RNA and protein samples were
collected accordingly at the end of experiments.
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Figure 1. Cerebral endothelial cell (CEC)–exosomes (exos) applied to distal axons promote axonal growth.
Representative confocal microscopic images show axonal growth at 24 h (A) and time-lapse microscopic images of growth cone extension (C)
and quantitative data of distal axonal growth at 24 and 48 h (B) and growth cone extension during a 24-h period (D), respectively. Yellow and red
arrows in C indicate the start (0′) and end positions (60′), respectively. isCEC-exos indicates exosomes isolated from cerebral endothelial cells of
ischemic rats. *P<0.05, ***P<0.001 vs control; #P<0.05, ###P<0.001 vs exos isolated from CECs of nonischemic rats (nCEC-exos).

Fluorescent in situ hybridization analysis further verified
isCEC-exos substantially increased miR-27a and miR19a in axons and growth cones (Figure VA in the Data
Supplement). These data indicate that the increased
4 miRNAs in axons were associated with their enrichment within CEC-exos.
It is possible that the augmented miRNAs could be
endogenously induced by axons of neurons upon CECexo uptake, rather than transferred by CEC-exos. Mature
miRNAs are derived from Dicer-cleaved premiRNAs,
while Dicer and premiRNAs are present in distal axons
of neurons.15,32 We thus examined premiRNA levels of
the 4 miRNAs within CEC-exos and in axons and somata
of cortical neurons. Quantitative RT-PCR analysis did
not detect these 4 premiRNAs within nCEC-exos and
isCEC-exos (Table VII in the Data Supplement). However, application of nCEC-exos into the axonal compartment for 4 hours increased the levels of 4 premiRNAs in
distal axons and their parent somata, with more robust
3704   December 2020

elevation of these premiRNAs in samples collected from
the cell body compartment (Figure 2C) than in samples
from the axon compartment (Figure 2D). Compared with
nCEC-exos, isCEC-exos further elevated these premiRNAs in axons and their somata (Figure 2C and 2D). Moreover, nCEC-exos and isCEC-exos significantly increased
mature forms of these 4 miRNAs in the cell bodies
(Figure VB in the Data Supplement). Western blotting
analysis showed that application of CEC-exos into the
axonal compartment for 4 hours did not alter the levels
of Dicer and Ago2 (Argonaute2) in distal axons and in
their parent somata, suggesting that CEC-exos did not
affect levels of the miRNA synthesis machinery proteins
(Figure VC in the Data Supplement). Collectively, these
data suggest that in addition to transferring their cargo
miRNAs to recipient neurons, CEC-exos applied into the
distal axons trigger endogenous miRNA synthesis in the
somata of cortical neurons, leading to increased premiRNAs and mature miRNAs.
Stroke. 2020;51:3701–3712. DOI: 10.1161/STROKEAHA.120.031728
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Figure 2. The effect of cerebral endothelial cell (CEC)–exosomes (exos) on levels of mature and precursor miRNAs and miRNA
machinery proteins of cortical neurons.
Scatterplot and heat map of miRNA polymerase chain reaction (PCR) array data demonstrate the differential miRNAs in exos (A, top), and the
differential miRNAs in axons after axonal application of CEC-exos (B, top). Quantitative reverse transcription PCR data show the mature miRNAs
in exos (A, bottom), mature (B, bottom) and precursor miRNAs (C) in axons, and mature miRNAs in somata (D) after the axonal application
of CEC-exos, respectively. The heat map images only listed partial miRNAs, and please view all miRNAs measured in Figure IV in the Data
Supplement. isCEC-exos indicates exosomes isolated from cerebral endothelial cells of ischemic rats. *P<0.05 vs exos isolated from CECs of
nonischemic rats (nCEC-exos) in A vs control in B–D; #P<0.05 vs nCEC-exos in B–D.

Axonal miRNAs regulate axonal growth by locally
modulating protein composition.15,23,33 We thus performed bioinformatics analysis by means of Ingenuity
Stroke. 2020;51:3701–3712. DOI: 10.1161/STROKEAHA.120.031728

Pathway Analysis, which revealed a network of miR27a, 19a, 298, and 195 and their putative target genes
(Figure 3A) that include well-known axon-inhibitory
December 2020   3705
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Figure 3. The effect of cerebral endothelial cell (CEC)–exosomes (exos) on levels of proteins in cortical neurons.
A miRNA/target genes network generated by Ingenuity Pathway Analysis (A). Representative Western blot images and quantitative data (B,
n=5/group) show axonal application of exos isolated from CECs of nonischemic rats (nCEC-exos) or exos isolated from CECs of ischemic rats
(isCEC-exos) on levels of Sema6A (semaphorin 6A), PTEN, and RhoA in distal axons (Axon) and cell bodies (Soma). Quantitative data of axon
length (C), representative Western blot images, and their quantitative data (D) show axonal application of Sema6A-Fc or chondroitin sulfate
proteoglycans (CSPGs) in the presence or absence of nCEC-exos or isCEC-exos, respectively, on axonal growth (C) and the axonal levels of
RhoA (D). NCAM1 indicates neural cell adhesion molecule 1; PTEN, phosphatase and tensin homolog; RhoG, ras homolog family member G;
RTN, reticulon; and SEMA7A, semaphorin 7A. *P<0.05 vs control; #P<0.05 vs nCEC-exos.

proteins, Sema6A, PTEN (Phosphatase and tensin
homolog), and RhoA (Ras homolog family member A).15,34–36 Western blotting analysis showed that
treatment of axons with nCEC-exos or isCEC-exos
reduced neuronal levels of PTEN, RhoA, and Sema6A
in axons and somata, whereas treatment with isCECexos induced a significantly greater reduction of these
proteins than treatment with nCEC-exos (Figure 3B).
These results suggest that the CEC-exos-elevated
the 4 miRNAs could potentially target genes encoding
these axonal inhibitory proteins in axons and somata. We
thus examined whether CEC-exosomal cargo miRNAs
contribute to the effect of CEC-exos on axonal growth.
CEC-exos isolated from CECs transfected with shRNA
against Dicer (dp-Dicer-exos) had a broad reduction of
Dicer-related miRNAs compared with cargo miRNAs
of CEC-exos derived from CECs transfected with control shRNAs (con-exos; Figure VIA and VIB in the Data
3706   December 2020

Supplement). Treatment of axons with dp-Dicer-exos
did not significantly enhance axonal growth (Figure VIC
in the Data Supplement), indicating that CEC-exo cargo
miRNAs are required for promoted axonal growth.
RhoA is a center node among genes in the miRNA/
target network (Figure 3A). We thus further examined the
effect of RhoA on CEC-exo–enhanced axonal growth.
Application of nCEC-exos into the axonal compartment
in the presence of CSGPs that are known to activate
RhoA23 in axons abolished nCEC-exo–augmented axonal growth, which was associated with an increase of
RhoA (Figure 3C and 3D). Moreover, soluble Sema6AFc also inhibited nCEC-exo–enhanced axonal growth
and increased RhoA protein (Figure 3C and 3D). However, individually adding CSPGs or soluble Sema6A-Fc
into the axonal compartment did not significantly affect
isCEC-exo–augmented axonal growth and did not alter
isCEC-exo–reduced RhoA, although CSPGs or soluble
Stroke. 2020;51:3701–3712. DOI: 10.1161/STROKEAHA.120.031728
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Axonal Transport Contributes to Axon-Applied
CEC-Exo–Induced Endogenous miRNA
Regulation
Aforementioned data that premiRNAs and mature miRNAs in axons and somata increased by axonal application of CEC-exos suggest that there is a communication
between distal axons and their parent somata. To examine
the effect of CEC-exos on this communication, a triplecompartment device (TCND500) was used (Figure IIA
and IIB in the Data Supplement). We found axonal application of nCEC-exos promotes axonal transport. However, the isCEC-exos exhibited further enhancement of
axonal transport than nCEC-exos (Figure II in the Data
Supplement). Emetine is a global protein synthesis inhibitor and has been widely used to study axonal transport.37,38
Transient application of emetine alone for 4 hours to the

proximal axon compartment inhibited bidirectional axonal
transport up to 4 hours (Figure VII in the Data Supplement). We thus assessed whether transient blockage of
axonal transport affects the endogenous miRNA expression induced by isCEC-exos. isCEC-exos applied into distal axons after emetine removal (Figure 4A) for 2 hours
did not significantly increase the selected premiRNAs
in distal axons and somata (Figure 4B and 4C). In contrast, levels of mature miRNAs in the distal axons were
significantly increased at 2 hours after isCEC-exos treatment (Figure 4B, bottom), whereas levels of these mature
miRNAs in the somata did not significantly change (Figure 4C, bottom). These data suggest that blockage of axonal transport between distal axons and their parent cell
bodies affects premiRNA but not mature miRNA levels
in distal axons altered by isCEC-exos. However, 4 hours
after the isCEC-exos application, a significant augmentation of premiRNAs was detected in somata (Figure 4C,
top) but not in distal axons (Figure 4B, top). By 12 hours,
these premiRNAs were significantly elevated in both distal axons (Figure 4B, top) and somata (Figure 4C, top).
Western blot analysis showed that when isCEC-exos
were applied into the distal axon for 2 hours after emetine
removal (Figure 5A), isCEC-exos reduced protein levels
of Sema6A, PTEN, and RhoA only in distal axons but did
not alter these protein levels in somata (Figure 5A). At 4

Figure 4. The transient blockage of axonal transport on exosomes isolated from cerebral endothelial cells of ischemic rat
(isCEC-exo)–altered miRNAs in cortical neurons.
A schematic (A) shows a workflow of collecting samples in distal axons and somata in TCND500 after transient proximal axonal application of
emetine and followed distal axonal application of isCEC-exos. Quantitative reverse transcription PCR data show levels of selected precursor
(top) and mature (bottom) miRNAs in the distal axons (B) and somata (C) after the distal axonal application of isCEC-exos for 0, 2, 4, and 12 h,
respectively, following emetine removal. *P<0.05 vs control.
Stroke. 2020;51:3701–3712. DOI: 10.1161/STROKEAHA.120.031728
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Sema6A-Fc by themselves significantly inhibited axonal growth and increased RhoA (Figure 3C and 3D).
In contrast, when they were added together, CSPGs
and soluble Sema6A-Fc blocked isCEC-exo–enhanced
axonal growth and significantly increased RhoA (Figure 3C and 3D). These data suggest that reduction of
RhoA is critical to nCEC-exo–enhanced and isCECexo–enhanced axonal growth.

Exosomes and Axonal Growth
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Figure 5. The transient blockage of axonal transport on exosomes isolated from cerebral endothelial cells of ischemic rat
(isCEC-exo)–altered proteins in cortical neurons.
Representative Western blot images and quantitative data show the levels of Sema6A, PTEN, and RhoA in distal axons (Distal Axon) and cell
bodies (Soma) after the distal axon application of isCEC-exos for 2 h (A) or 4 h (B), respectively, following emetine removal. PTEN indicates
phosphatase and tensin homolog; RhoA, ras homolog family member A; and Sema6A semaphorin 6A. *P<0.05 vs control.

hours, significant decreases of Sema6A, PTEN, and RhoA
proteins were detected in both distal axons and somata
(Figure 5B). Furthermore, we found transient application
of emetine alone significantly decreased the speed of axonal growth in the distal axon compartment, which gradually
recovered 12 hours after removing emetine (Figure VIII in
the Data Supplement). Application of isCEC-exos in distal
axons after emetine removal did not significantly increase
axonal growth until application for 4 hours (Figure VIII in
the Data Supplement). Transient application of emetine
alone to the proximal axon compartment did not significantly change levels of premiRNAs and mature miRNAs in
the distal axon and cell body compartments (Figure IX in
the Data Supplement). These data suggest that a network
of miRNAs and proteins regulated by CEC-exos in recipient neurons is involved in CEC-exos–enhanced axonal
growth, which likely occurs via a communication between
distal axons and their parent somata.

CEC-Exos Are Internalized by Distal Axons and
Reach to Parental Cell Bodies
To examine whether CEC-exos are internalized by axons,
we imaged Texas Red–labeled nCEC-exos applied to the
axonal compartment. Confocal microscopic images showed
red fluorescent signals were detected within GFP (green
3708   December 2020

fluorescent protein)-positive axons and growth cones (Figure 6A), suggesting the axonal internalization of nCEC-exos.
To further examine whether exogenous CEC-exos are
internalized by axons and reach to their parent cell bodies, we generated GFP carrying CEC-GFP-exos (Figure
X in the Data Supplement) and applied CEC-GFP-exos
into the axonal compartment for 4 hours. Transmission
electron microscope analysis revealed GFP-positive gold
particles within neurofilaments and mitochondria of the
treated axons (Figure 6B and 6C), whereas GFP-positive gold particles were not detected when the primary
antibody against GFP was omitted (Figure XI in the Data
Supplement), indicating that CEC-exos are internalized
by axons. Moreover, GFP-positive gold particles were
also detected in cytoplasm and nucleus of neuronal cell
bodies (Figure 6D), suggesting that CEC-exos internalized by axons reach to their parent cell bodies.

DISCUSSION
The present study demonstrated that exosomes derived
from nonischemic and ischemic CECs enhanced axonal
growth. More importantly, the CEC-exos internalized by
distal axons triggered upregulation of miRNAs, which was
associated with targeted reduction of axonal inhibitory proteins in recipient neurons. These novel data suggest that
Stroke. 2020;51:3701–3712. DOI: 10.1161/STROKEAHA.120.031728
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Figure 6. Axonal application of cerebral endothelial cell (CEC)–exosomes (exos) is internalized by axons and reach to their
parent cell bodies.
Confocal microscopic images show the internalization of Texas Red–labeled exos isolated from CECs of nonischemic rats in axons and growth cone
(exos, white arrows). Representative transmission electron microscope images show the presence of GFP-positive gold particles (black arrows) in
axonal growth cone in the axonal compartment (B), axon bundles in microgrooves (C), and neuronal cell bodies in the soma compartment (D). B1,
B2, B3 and C1, C2, C3 are magnified regions in B and C, respectively. GFP indicates green fluorescent protein; M, mitochondria; and N, nucleus.
Stroke. 2020;51:3701–3712. DOI: 10.1161/STROKEAHA.120.031728
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CEC-released exosomes play an important role in mediating
axonal homeostasis and axonal plasticity under physiological and ischemic conditions, respectively. This is so particularly in light of the fact that activated CECs contribute to
improvement of neurological function, while axonal remodeling in ischemic brain is required for stroke recovery.39,40
The dynamic interaction between CECs and neurons in
the neurovascular unit plays an essential role in the maintenance of brain homeostasis.41,42 Exosomes mediate communication among brain cells that include neurons, glia,
and blood vessel cells.43–45 CECs release exosomes46,47;
however, how the endothelium-derived exosomes communicate with brain parenchymal cells, in particular with
neurons, remains unknown. The present in vitro study provides evidence that exosomes derived from nonischemic
endothelial cells promote axonal growth. Furthermore,
exosomes derived from ischemic endothelial cells have
a more robust effect on promoting axonal growth. Limited axonal growth has been demonstrated in peri-infarct
regions after stroke.1,48 We previously demonstrated that
primary CECs isolated from the ischemic brain exhibit
distinct RNA and protein profiles and angiogenic activity
compared with CECs harvested from nonischemic brain,
although the isCECs were cultured under the normoxia
condition.20 The present findings suggest that isCEC-exos
contribute to axonal remodeling in ischemic brain. In addition to axons, our data show that CEC-exos internalized by
distal axons reached to their cell bodies, suggesting that
CEC-exos could affect dendritic plasticity, which warrants
further investigation. Together, data from the present study
and others suggest that in addition to factors released by
CECs, the endothelium-generated exosomes mediate neuronal function and that administration of CEC-exos could
potentially enhance neuronal remodeling in ischemic brain.
Exosomes mediate intercellular communication by
transferring their cargo including proteins and miRNAs
between source and recipient cells and consequently regulate biological function of recipient cells.9,10 Emerging data
indicate that exosomes affect axonal function by delivering
their cargo30,49; however, there are few studies that investigate how exosomal cargo alters gene and protein profiles
that eventually determine the biological function of recipient neurons. Stroke alters miRNA expression in CECs,50,51
but it remains unknown whether stroke changes miRNA
profiles in CEC-exos. Using multiple approaches, the present study suggests that exosomes internalized by distal
axons regulate a network of miRNA/target locally in distal
axons and remotely in their cell bodies, which impact axonal
growth. We first demonstrated that CEC-exos were rapidly
internalized by distal axons, which led to elevation of CECexo–enriched mature miRNAs, initially in the distal axons
and later in somata, indicating that CEC-exos elevate axonal miRNAs. We then showed that in addition to mature
miRNAs, precursors of mature miRNAs were increased
in somata and distal axons. premiRNAs are synthesized
in the nucleus and are then exported to cytoplasm where
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they are processed into mature miRNAs by Dicer.32,52
Since CEC-exos only contained mature miRNAs, elevated
premiRNAs are likely transported anterogradely from neuronal cell bodies to the axons. Indeed, our ultrastructural
data showed that CEC-exos were internalized by distal
axons and reached the cytoplasm and nucleus of neuronal cells, which provide strong evidence to support that the
CEC-exo cargo regulates miRNA expression in recipient
neurons. Moreover, transient blocking of axonal transport
resulted in reduction of premiRNA levels in distal axons,
while resuming transiently blocked axonal transport led to
elevation of premiRNAs in distal axons treated with CECexos. In addition, premiRNAs and Dicer were present in
distal axons, whereas CEC-exos only contained mature
miRNAs. Augmentation of mature miRNAs and reduction
of premiRNAs in distal axons by CEC-exos under conditions of axonal transport blockage suggest that increased
mature miRNAs either from CEC-exos or from preexisting
premiRNAs in the axon that have been locally converted
into mature miRNAs by Dicer. Studies have shown that
multivesicular bodies and mitochondria regulate axonal
transport.53–55 Our ultrastructural imaging data showed
that nCEC-exos were localized to mitochondria of axons
after axonal internalization (Figure 6). Thus, the roles of
multivesicular bodies and mitochondria in mediating CECexo–altered axonal transport warrant further investigation.
Selectively increased miRNAs in distal axons and
their cell bodies were inversely related to their target
gene encoded proteins, Sema6A, PTEN, and RhoA.
These proteins have been demonstrated as intrinsically
inhibitory proteins within neurons that suppress axonal growth.35,36,56 We and others have reported that the
CSGPs activate RhoA in axons, leading to inhibition of
axonal growth, and that inhibition of RhoA increases the
regeneration of axons.23,36 Using CSPGs and Sema6AFc that activate RhoA, the present study suggests that
reduction of RhoA plays an important role in mediating
CEC-exos–enhanced axonal growth. Others have shown
that suppression of axonal miR-338 leads to augmentation of mRNA and protein in one of its target genes, mitochondrial cytochrome C oxidase IV, in axons and somata
as early as 4 hours after transfecting.57 Collectively, the
present study suggests that in addition to transferring
cargo miRNAs, CEC-exos regulate endogenous miRNAs and their putative target protein profiles in recipient
neurons, leading to CEC-exo–enhanced axonal growth.
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